Apop Imaging will launch its patented CalRexin globally (> $450 mio/year market), to provide researchers with powerful new tools to image in vivo cell events.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free